The time has come to light the "lighthouse" of the next generation of life science — together.
As the convergence of AI and the life sciences enters the "computing power era",
competition in research is no longer about who discovers a model faster,
but about who can builda research ecosystem capable of sustainable evolution
Today, we are no longer content with discussion alone —
we are issuing a formal invitation and opening the door to co-creation.
Because we believe that
the ultimate value of a technology lies not in how much it can do,
but in how many partners it can empower to solve real-world problems.
Part.1 The "Lighthouse Program": lighting up the research ecosystem of the future 
The Elixir™ "Lighthouse Program" is officially launched,
with the aim of working alongside the world's leading research institutions, hospitals, biotechnology and pharmaceutical companies
to jointly build an open, co-created and mutually beneficial intelligent research ecosystem.
Part.2 Why build a shared "foundation"?
In the view of Elixir™, the future of the life sciences
does not belong to those who achieve a single-point breakthrough,
but to those system collaborators who can bring data, algorithms and the clinic into genuine fusion.
The research model of the past was an "island" model:
each laboratory held its own data, algorithms and models, which were almost impossible to reuse.
The Elixir™ large-model foundation provides a unified intelligent base —
● AI foundation capabilities pre-trained on 160,000 samples
● rapid fine-tuning, with support for transfer across multiple disease tasks
● strict data security and compliance standards
▍ This means partners no longer have to start from scratch,
▍ and can quickly generate, validate and deploy their own research models on the Elixir™ foundation.
Part.3 Three co-creation models: illuminating the uncharted waters of precision medicine
The "Lighthouse Program" expresses our wish to become a guide for research and industry, working with partners to illuminate disease mechanisms, molecular features and systems biology networks that are not yet understood.
● Model one: data co-creation — sharing the value of future data
For research institutions and hospitals that hold high-quality cohort data.
Under strict ethical and privacy protection,
jointly expand the cognitive boundaries of Elixir™,
and share the long-term research and commercial value generated by the data asset.
● Model two: algorithm co-creation — building your own "model factory"
For institutions that wish to build and commercialise AI models of their own.
We open up the underlying fine-tuning platform and APIs,
helping you rapidly build, train, validate and privately deploy models on the Elixir™ foundation,
while gaining commercial licensing and joint brand promotion opportunities.
● Model three: clinical co-research — an accelerator from laboratory to ward
For hospitals and expert teams committed to solving clinical pain points.
Co-define the scientific questions, share IP outcomes, publish high-impact papers together,
and drive innovative models into genuine clinical application.
Part.4 Exclusive benefits for "Lighthouse Partners"
Joining the Elixir™ partnership programme means gaining:
▶ Direct access to the AI computing power and analytics of the Elixir™ foundation
▶ Priority authorship rights for research publications and result translation
▶ End-to-end technical support for model fine-tuning and validation
▶ API access for interconnected research data
▶ Priority participation in joint industry research and international collaboration projects
▍ Research collaboration is no longer an exchange of resources,
▍ but a symbiosis of capability and a win-win of value.
Part.5 Your field, your "lighthouse"
The Elixir™ large model is a "key" we are handing to the industry.
Now we sincerely invite you to take up that key and join us:
for pharmaceutical companies, accelerating target discovery and clinical trials;
for hospitals, reshaping the pathways of disease diagnosis and prognosis management;
for research institutions, opening the door to the biology of unknown diseases.
Every co-creator is a source of light for the lighthouse;
every collaboration is a direction that illuminates the future.
Let us join hands —
open co-creation, building the future together,
and lighting up the next era of intelligent research.
